Filing Details
- Accession Number:
- 0001628280-24-009014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 17:13:45
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-05 17:13:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1938826 | Craig Geoffrey Porges | 1540 Broadway, 24Th Floor New York NY 10036 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-04 | 9,000 | $0.00 | 9,000 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-03-04 | 3,315 | $26.35 | 5,685 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2024-03-04 | 90,000 | $0.00 | 90,000 | $25.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
90,000 | 2034-03-04 | No | 4 | A | Direct |
Footnotes
- Represents the portion of the performance-based restricted stock units ("PRSUs") that were awarded to the reporting person on August 18, 2022 in connection with the commencement of his employment that vested on March 4, 2024 following certification by the compensation committee of the issuer's board of directors of the level of achievement of certain performance metrics for the PRSUs.
- This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on August 16, 2022 and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of the PRSUs on March 4, 2024. The sale does not represent a discretionary trade by the reporting person.
- The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.